Current Protein Identity:P27958 New Search
Main Difference Dimensions in This Set
Different construct Different mutation/modification Different assembly state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics

Difference tags compare only the current result set; every original PDB and assembly record remains separate.

Related-Structure Differences

Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.

PDB Entry Assembly / Oligomeric State Construct Mutations and Modifications Ligands, Ions and Non-polymers Experimental Method Experimental Conditions Structure Quality
1A1R HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX Deposited 1997-12-15 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1026–1205(180 aa) Fragment:PROTEASE DOMAIN
Chain C 1677–1695(19 aa) Fragment:ACTIVATION DOMAIN
Mutation:INS(ASMTGGQQMG) AT N-TERMINUS, INS(GSHHHHHH) AT C-TERMINUS Mutation:INS(KK) AT N-TERMINUS, C22S, INS(KK) AT C-TERMINUS ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;PROTEIN WAS CRYSTALLIZED FROM 1.8 M NACL, 100 MM NA/K PHOSPHATE, 10 MM B-MERCAPTOETHANOL, 100 MM MES, PH 6.5.
Resolution 2.50 Å R-free 0.261
1A1R HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX Deposited 1997-12-15 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1026–1205(180 aa) Fragment:PROTEASE DOMAIN
Chain D 1677–1695(19 aa) Fragment:ACTIVATION DOMAIN
Mutation:INS(ASMTGGQQMG) AT N-TERMINUS, INS(GSHHHHHH) AT C-TERMINUS Mutation:INS(KK) AT N-TERMINUS, C22S, INS(KK) AT C-TERMINUS ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;PROTEIN WAS CRYSTALLIZED FROM 1.8 M NACL, 100 MM NA/K PHOSPHATE, 10 MM B-MERCAPTOETHANOL, 100 MM MES, PH 6.5.
Resolution 2.50 Å R-free 0.261
1A1R HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX Deposited 1997-12-15 Assembly 3 Protein homooligomer Homooligomer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1026–1205(180 aa) Fragment:PROTEASE DOMAIN
Chain B 1026–1205(180 aa) Fragment:PROTEASE DOMAIN
Chain C 1677–1695(19 aa) Fragment:ACTIVATION DOMAIN
Chain D 1677–1695(19 aa) Fragment:ACTIVATION DOMAIN
Mutation:INS(ASMTGGQQMG) AT N-TERMINUS, INS(GSHHHHHH) AT C-TERMINUS Mutation:INS(ASMTGGQQMG) AT N-TERMINUS, INS(GSHHHHHH) AT C-TERMINUS Mutation:INS(KK) AT N-TERMINUS, C22S, INS(KK) AT C-TERMINUS Mutation:INS(KK) AT N-TERMINUS, C22S, INS(KK) AT C-TERMINUS ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;PROTEIN WAS CRYSTALLIZED FROM 1.8 M NACL, 100 MM NA/K PHOSPHATE, 10 MM B-MERCAPTOETHANOL, 100 MM MES, PH 6.5.
Resolution 2.50 Å R-free 0.261
1A1V HEPATITIS C VIRUS NS3 HELICASE DOMAIN COMPLEXED WITH SINGLE STRANDED SDNA Deposited 1997-12-17 Assembly 1 Protein–DNA Monomer;Protein × 1 PDB declaration: dimeric(2) Consistent with all polymers
Chain A 1193–1657(465 aa) Fragment:HELICASE DOMAIN
Mutation:;N-TERMINAL MET, K221Q, A277G, S301L, S332P, S410A, G530E, R582W, AND A 10 RESIDUE (GSGSHHHHHH) HISTIDINE TAG ATTACHED TO THE C-TERMINUS ; Non-standard monomer:Yes (specific site not provided by mmCIF) SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions pH 8;pH 8.0
Resolution 2.20 Å R-free 0.287
1CWX SOLUTION STRUCTURE OF THE HEPATITIS C VIRUS N-TERMINAL CAPSID PROTEIN 2-45 [C-HCV(2-45)] Deposited 1999-08-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2–45(44 aa) Fragment:N-TERMINAL FRAGMENT
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 5.9;293 K;Ionic strength (raw mmCIF value) 0.1M NACL;Pressure AMBIENT
NMR sample composition 40% D2-TRIFLUOROETHANOL;0.01M SODIUM PHOSPHATE;0.1M NACL
Resolution not provided
1HEI STRUCTURE OF THE HEPATITIS C VIRUS RNA HELICASE DOMAIN Deposited 1997-03-31 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1206–1656(451 aa)
Chain B 1206–1656(451 aa)
Not recorded CA CALCIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;50MM CA ACETATE, 20MM NACACODYLATE PH 6.5, 8% PEG5000
Resolution 2.10 Å R-free 0.320
1JR6 Solution Structure of an Engineered Arginine-rich Subdomain 2 of the Hepatitis C Virus NS3 RNA Helicase Deposited 2001-08-10 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1353–1507(155 aa) Fragment:arginine-rich subdomain 2
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.5;298 K;Ionic strength (raw mmCIF value) 75 mM KiPO4;Pressure ambient
NMR sample composition 0.6 mM, U-15N,13C; | 75 mM PHOSPHATE BUFFER; 5 mM DTT, 90%H2O, 10%D2O, 0.015% NaN3
NMR sample composition 0.6 mM, U-15N,13C; | 75 mM PHOSPHATE BUFFER; 5 mM DTT, 99%D2O, 0.015% NaN3
NMR sample composition 0.3 mM, U-15N | 75 mM PHOSPHATE BUFFER; 5 mM DTT, 90%H2O, 10%D2O, 0.015% NaN3
Resolution not provided
1N1L CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND INHIBITOR (GW472467X) Deposited 2002-10-18 Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 1026–1205(180 aa) Fragment:Protease domain
Mutation:A164T ZN ZINC ION × 1 TRL {1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Inhibitor soaked into crystal generated according to Kim et al. (1996) Cell, 87, 343-355, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.0K
Resolution 2.60 Å R-free 0.220
1N1L CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND INHIBITOR (GW472467X) Deposited 2002-10-18 Assembly 2 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain B 1026–1205(180 aa) Fragment:Protease domain
Mutation:A164T ZN ZINC ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Inhibitor soaked into crystal generated according to Kim et al. (1996) Cell, 87, 343-355, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.0K
Resolution 2.60 Å R-free 0.220
1N1L CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND INHIBITOR (GW472467X) Deposited 2002-10-18 Assembly 3 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1026–1205(180 aa) Fragment:Protease domain
Chain B 1026–1205(180 aa) Fragment:Protease domain
Mutation:A164T Mutation:A164T ZN ZINC ION × 2 TRL {1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 6.5;277 K;Inhibitor soaked into crystal generated according to Kim et al. (1996) Cell, 87, 343-355, pH 6.5, VAPOR DIFFUSION, SITTING DROP, temperature 277.0K
Resolution 2.60 Å R-free 0.220
1ONB Solution structure of an engineered arginine-rich subdomain 2 of the hepatitis C virus NS3 RNA helicase Deposited 2003-02-27 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1353–1507(155 aa) Fragment:Arginine-rich subdomain 2
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.5;298 K;Ionic strength (raw mmCIF value) 75 mM KIPO4;Pressure ambient
NMR sample composition 0.6 mM, U-15N,13C | 90% H2O/10% D2O
NMR sample composition 0.6 mM, U-15N,13C | 99.9%D2O
Resolution not provided
1R7C NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of hepatitis C virus (Minimized average structure, Sample in 50% tfe) Deposited 2003-10-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1973–2003(31 aa) Fragment:Nonstructural protein NS5A (P56)(residues 1973-2003 OF SWISS-PROT SEQUENCE P27958)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 4.5;293 K;Pressure ambient
NMR sample composition 1.2mM NS5A[1-31], 10mM DTTd10 | H2O/TFEd2 50/50 (v/v)
Resolution not provided
1R7D NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of hepatitis C virus (Ensemble of 51 structures, sample in 50% tfe) Deposited 2003-10-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1973–2003(31 aa) Fragment:Nonstructural protein NS5A (P56)(residues 1973-2003 of Swiss-Prot sequence P27958)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 4.5;293 K;Pressure ambient
NMR sample composition 1.2mM NS5A[1-31], 10mM DTTd10 | H2O/TFEd2 50/50 (v/v)
Resolution not provided
1R7E NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of hepatitis C virus (Minimized average structure. Sample in 100mM SDS). Deposited 2003-10-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1973–2003(31 aa) Fragment:Nonstructural protein NS5A (P56)(residues 1973-2003 OF SWISS-PROT SEQUENCE P27958)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6;313 K;Pressure ambient
NMR sample composition 1.2mM NS5A[1-31], 10mM DTTd10 | 100mM SDS in H2O/D2O 95/5 (v/v)
Resolution not provided
1R7F NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of hepatitis C virus (Ensemble of 43 structures. Sample in 100mM SDS) Deposited 2003-10-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1973–2003(31 aa) Fragment:Nonstructural protein NS5A (P56)(residues 1973-2003 of Swiss-Prot sequence P27958)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6;313 K;Pressure ambient
NMR sample composition 1.2mM NS5A[1-31], 10mM DTTd10 | 100mM SDS in H2O/D2O 95/5 (v/v)
Resolution not provided
1R7G NMR structure of the membrane anchor domain (1-31) of the nonstructural protein 5A (NS5A) of hepatitis C virus (Minimized average structure, Sample in 100mM DPC) Deposited 2003-10-21 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1973–2003(31 aa) Fragment:Nonstructural protein NS5A (P56)(residues 1973-2003 OF SWISS-PROT SEQUENCE P27958)
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6;313 K;Pressure ambient
NMR sample composition 1.2mM NS5A[1-31], 10mM DTTd10 | 100mM DPC in H2O/D2O 95/5 (v/v)
Resolution not provided
1RGQ M9A HCV Protease complex with pentapeptide keto-amide inhibitor Deposited 2003-11-12 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain A 1026–1206(181 aa) Fragment:RESIDUES 1027-1207
Chain B 1026–1206(181 aa) Fragment:RESIDUES 1027-1207
Not recorded ZN ZINC ION × 2 AKP N-(PYRAZIN-2-YLCARBONYL)LEUCYLISOLEUCYL-N~1~-{1-[2-({1-CARBOXY-2-[4-(PHOSPHONOOXY)PHENYL]ETHYL}AMINO)-1,1-DIHYDROXY-2-OXOETHYL]BUT-3-ENYL}-3-CYCLOHEXYLALANINAMIDE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.2M N/KPO4, 2.0M NaCl, 10mM MES, 15% glycerol, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 298K
Resolution 2.90 Å R-free 0.312
2HD0 Structure of the catalytic domain of hepatitis C virus NS2 Deposited 2006-06-19 Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain A 902–1025(124 aa) Fragment:protease domain of NS2
Chain B 902–1025(124 aa) Fragment:protease domain of NS2
Not recorded BOG octyl beta-D-glucopyranoside × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;0.1 M Tris pH 8.5 0.8 M Ammonium Acetate 0.25 M Lithium Chloride 12% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
Resolution 2.28 Å R-free 0.268
2HD0 Structure of the catalytic domain of hepatitis C virus NS2 Deposited 2006-06-19 Assembly 2 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain C 902–1025(124 aa) Fragment:protease domain of NS2
Chain D 902–1025(124 aa) Fragment:protease domain of NS2
Not recorded BOG octyl beta-D-glucopyranoside × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;0.1 M Tris pH 8.5 0.8 M Ammonium Acetate 0.25 M Lithium Chloride 12% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
Resolution 2.28 Å R-free 0.268
2HD0 Structure of the catalytic domain of hepatitis C virus NS2 Deposited 2006-06-19 Assembly 3 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain E 902–1025(124 aa) Fragment:protease domain of NS2
Chain F 902–1025(124 aa) Fragment:protease domain of NS2
Not recorded BOG octyl beta-D-glucopyranoside × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;0.1 M Tris pH 8.5 0.8 M Ammonium Acetate 0.25 M Lithium Chloride 12% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
Resolution 2.28 Å R-free 0.268
2HD0 Structure of the catalytic domain of hepatitis C virus NS2 Deposited 2006-06-19 Assembly 4 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain G 902–1025(124 aa) Fragment:protease domain of NS2
Chain H 902–1025(124 aa) Fragment:protease domain of NS2
Not recorded BOG octyl beta-D-glucopyranoside × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;0.1 M Tris pH 8.5 0.8 M Ammonium Acetate 0.25 M Lithium Chloride 12% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
Resolution 2.28 Å R-free 0.268
2HD0 Structure of the catalytic domain of hepatitis C virus NS2 Deposited 2006-06-19 Assembly 5 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain I 902–1025(124 aa) Fragment:protease domain of NS2
Chain J 902–1025(124 aa) Fragment:protease domain of NS2
Not recorded BOG octyl beta-D-glucopyranoside × 2 DMU DECYL-BETA-D-MALTOPYRANOSIDE × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;0.1 M Tris pH 8.5 0.8 M Ammonium Acetate 0.25 M Lithium Chloride 12% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
Resolution 2.28 Å R-free 0.268
2HD0 Structure of the catalytic domain of hepatitis C virus NS2 Deposited 2006-06-19 Assembly 6 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric(2) Consistent with protein count
Chain K 902–1025(124 aa) Fragment:protease domain of NS2
Chain L 902–1025(124 aa) Fragment:protease domain of NS2
Not recorded BOG octyl beta-D-glucopyranoside × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;277 K;0.1 M Tris pH 8.5 0.8 M Ammonium Acetate 0.25 M Lithium Chloride 12% PEG 3350, VAPOR DIFFUSION, HANGING DROP, temperature 277.0K
Resolution 2.28 Å R-free 0.268
2JXF The solution structure of HCV NS4B(40-69) Deposited 2007-11-19 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 1751–1780(30 aa) Fragment:Non-structural protein 4B, UNP residues 1751-1780
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6.5;298 K;Ionic strength (raw mmCIF value) 0;Pressure ambient
NMR sample composition 1mM NS4B(40-69); 50% v/v Trifluoro Ethanol D2OH; 50% v/v H2O | 50% v/v Trifluoro Ethanol D2OH; 50% v/v H2O
Resolution not provided
2KDR Solution structure of HCV NS4B(227-254) Deposited 2009-01-15 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain X 1938–1965(28 aa) Fragment:UNP residues 1938-1965
Not recorded No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions pH 6;298 K;Ionic strength (raw mmCIF value) none;Pressure ambient
NMR sample composition 2mM protein-1, 50% v/v Trifluoro Ethanol D2OH; 50% v/v H2O | 50% v/v Trifluoro Ethanol D2OH; 50% v/v H2O
Resolution not provided
2N1P Structure of the C-terminal membrane domain of HCV NS5B protein Deposited 2015-04-15 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2982–3011(30 aa) Fragment:C-terminal domain (UNP residues 2982-3011)
Mutation:C14S No recorded non-water small molecule SOLUTION NMR
NMR measurement conditions 298 K;Pressure ambient
NMR sample composition 1.4 mM protein, 1 M [U-2H] SDS, 95% H2O/5% D2O | 95% H2O/5% D2O
Resolution not provided
2O8M Crystal structure of the S139A mutant of Hepatitis C Virus NS3/4A protease Deposited 2006-12-12 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain C 1677–1695(19 aa)
Chain D 1677–1695(19 aa)
Not recorded ZN ZINC ION × 2 NA SODIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;1.25 to 1.5M NaCl, 0.1 M MES, .1M Na/K PO4, 5mM beta-mercaptoethanol, pH 5.6-6.2, VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 2.00 Å R-free 0.228
2OBQ Discovery of the HCV NS3/4A Protease Inhibitor SCH503034. Key Steps in Structure-Based Optimization Deposited 2006-12-19 Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric(4) Consistent with protein count
Chain B 1677–1695(19 aa)
Chain D 1677–1695(19 aa)
Mutation:C22S Mutation:C22S ZN ZINC ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;277 K;The protein (NS3 complexed with KK-NS4a(21-39)-KK peptide) was at 12-15 mg/ml in 15 mM MES, pH 6.5 1 M NaCl 20 mM b-mercaptoethanol. Hanging Drops were formed by mixing 4:l protein solution with 4:l {0.75-1.0 M NaCl, 0.1M Na/K phosphate 0.1 M Mes, pH 5.8-6.1 20 mM b-mercaptoethanol} The drop was equilibrated the drops over 1 ml {(1.25-1.50 M) NaCl - 0.1M Na/K phosphate 0.1 M Mes, pH 5.6-5.8, 20 mM b-mercaptoethanol} , VAPOR DIFFUSION, HANGING DROP, temperature 277K
Resolution 2.50 Å R-free 0.264
2XI2 HCV-H77 NS5B Apo Polymerase Deposited 2010-06-25 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2421–2990(570 aa) Fragment:CATALYTIC DOMAIN, RESIDUES 2421-2990
Mutation:YES SO4 SULFATE ION × 7 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;MES 0.1M PH 6.5, AMMONIUM SULFATE 0.2M, PEG 5000 MONOMETHYL ETHER
Resolution 1.80 Å R-free 0.207
2XI2 HCV-H77 NS5B Apo Polymerase Deposited 2010-06-25 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 2421–2990(570 aa) Fragment:CATALYTIC DOMAIN, RESIDUES 2421-2990
Mutation:YES SO4 SULFATE ION × 7 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;MES 0.1M PH 6.5, AMMONIUM SULFATE 0.2M, PEG 5000 MONOMETHYL ETHER
Resolution 1.80 Å R-free 0.207
2XI2 HCV-H77 NS5B Apo Polymerase Deposited 2010-06-25 Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain C 2421–2990(570 aa) Fragment:CATALYTIC DOMAIN, RESIDUES 2421-2990
Mutation:YES SO4 SULFATE ION × 6 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;MES 0.1M PH 6.5, AMMONIUM SULFATE 0.2M, PEG 5000 MONOMETHYL ETHER
Resolution 1.80 Å R-free 0.207
2XI3 HCV-H77 NS5B Polymerase Complexed With GTP Deposited 2010-06-25 Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain A 2421–2990(570 aa) Fragment:CATALYTIC DOMAIN, RESIDUES 2421-2990
Mutation:YES GTP GUANOSINE-5'-TRIPHOSPHATE × 3 MG MAGNESIUM ION × 3 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;MES 50MM PH 6.5, AMMONIUM SULFATE 0.2M, AMMONIUM ACETATE 0.25M, PEG 1000 25%-30%
Resolution 1.70 Å R-free 0.198
2XI3 HCV-H77 NS5B Polymerase Complexed With GTP Deposited 2010-06-25 Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric(1) Consistent with protein count
Chain B 2421–2990(570 aa) Fragment:CATALYTIC DOMAIN, RESIDUES 2421-2990
Mutation:YES GTP GUANOSINE-5'-TRIPHOSPHATE × 2 MG MAGNESIUM ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions pH 6.5;MES 50MM PH 6.5, AMMONIUM SULFATE 0.2M, AMMONIUM ACETATE 0.25M, PEG 1000 25%-30%
Resolution 1.70 Å R-free 0.198
4JZN Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC84-1 Deposited 2013-04-03 Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain K 434–446(13 aa) Fragment:Residues 434-446 of HCV strain H77 polyprotein
Not recorded SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;100mM TRIS pH 8.0 19% PEG4000 170mM Lithium Sulfate 15% Glycerol, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.05 Å R-free 0.235
4JZO Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC84-27 Deposited 2013-04-03 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain J 434–446(13 aa) Fragment:Residues 434-446 of HCV strain H77 polyprotein
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;23% PEG 3350 250mM Sodium Thiocyanate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.22 Å R-free 0.236
4JZO Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC84-27 Deposited 2013-04-03 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain K 434–446(13 aa) Fragment:Residues 434-446 of HCV strain H77 polyprotein
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;23% PEG 3350 250mM Sodium Thiocyanate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.22 Å R-free 0.236
4JZO Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC84-27 Deposited 2013-04-03 Assembly 3 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain I 434–446(13 aa) Fragment:Residues 434-446 of HCV strain H77 polyprotein
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;23% PEG 3350 250mM Sodium Thiocyanate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.22 Å R-free 0.236
4JZO Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC84-27 Deposited 2013-04-03 Assembly 4 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain L 434–446(13 aa) Fragment:Residues 434-446 of HCV strain H77 polyprotein
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;23% PEG 3350 250mM Sodium Thiocyanate, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.22 Å R-free 0.236
4MWF Structure of Hepatitis C Virus Envelope Glycoprotein E2 core bound to broadly neutralizing antibody AR3C Deposited 2013-09-24 Assembly 1 Other combination Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain D 412–459(48 aa)
Chain D 486–645(160 aa)
Mutation:N448D, N576D Mutation:N448D, N576D NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;20% (w/v) PEG 4000, 10% (v/v) isopropanol, and 0.1 M HEPES pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.65 Å R-free 0.270
4MWF Structure of Hepatitis C Virus Envelope Glycoprotein E2 core bound to broadly neutralizing antibody AR3C Deposited 2013-09-24 Assembly 2 Other combination Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain C 412–459(48 aa)
Chain C 486–645(160 aa)
Mutation:N448D, N576D Mutation:N448D, N576D NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;20% (w/v) PEG 4000, 10% (v/v) isopropanol, and 0.1 M HEPES pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
Resolution 2.65 Å R-free 0.270
4Q0X Crystal structure of non-neutralizing antibody in complex with Epitope II of HCV E2 Deposited 2014-04-02 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain E 421–446(26 aa) Fragment:epitope II (UNP residues 421-446)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;0.1 M imidazole, 14% w/v PEG550 MME, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
Resolution 2.90 Å R-free 0.285
5FGB Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.4 Deposited 2015-12-20 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain F 405–425(21 aa)
Not recorded GOL GLYCEROL × 2 SO4 SULFATE ION × 5 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.2;293 K;100 mM sodium citrate pH 5.2 300 mM ammonium sulfate 100 mM potassium phosphate 1 M lithium chloride
Resolution 1.65 Å R-free 0.190
5FGB Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.4 Deposited 2015-12-20 Assembly 2 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain G 405–425(21 aa)
Not recorded GOL GLYCEROL × 2 SO4 SULFATE ION × 2 X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 5.2;293 K;100 mM sodium citrate pH 5.2 300 mM ammonium sulfate 100 mM potassium phosphate 1 M lithium chloride
Resolution 1.65 Å R-free 0.190
5FGC Three dimensional structure of broadly neutralizing human anti - Hepatitis C virus (HCV) glycoprotein E2 Fab fragment HC33.8 Deposited 2015-12-20 Assembly 1 Protein heterocomplex Heteromer;Protein × 3 PDB declaration: trimeric(3) Consistent with protein count
Chain A 405–425(21 aa)
Not recorded No recorded non-water small molecule X-RAY DIFFRACTION
X-ray crystallization conditions VAPOR DIFFUSION, HANGING DROP;pH 8.5;293 K;32% PEG 4000 100 mM Tris-HCl pH 8.5 800 mM lithium chloride Crystals obtained using heterologous microseeding.
Resolution 1.90 Å R-free 0.236